Abstract
CCAAT/enhancer binding proteins (C/EBPs) are key-regulators of cell differentiation and linked processes such as proliferation, apoptosis and gene expression in several organs. C/EBPs are also central for inflammatory responses and infectious defenses, but so far little is known of their role in lung diseases. However, a role for these intracellular proteins has recently been suggested in asthma, lung cancer and chronic bronchitis-COPD. In this mini-review, an overview of the biological roles of C/EBPs in lung is provided, together with a discussion of the recent studies suggesting a role for these transcription factors in the pathogenesis of some of our most common and severe lung diseases.
Keywords: Lung, CCAAT/enhancer binding proteins, transcription factors, lung cancer, asthma, chronic bronchitis, chronic obstructive pulmonary disease
Current Respiratory Medicine Reviews
Title: C/EBP Transcription Factors in Lung Disease
Volume: 1 Issue: 3
Author(s): Magnus Nord
Affiliation:
Keywords: Lung, CCAAT/enhancer binding proteins, transcription factors, lung cancer, asthma, chronic bronchitis, chronic obstructive pulmonary disease
Abstract: CCAAT/enhancer binding proteins (C/EBPs) are key-regulators of cell differentiation and linked processes such as proliferation, apoptosis and gene expression in several organs. C/EBPs are also central for inflammatory responses and infectious defenses, but so far little is known of their role in lung diseases. However, a role for these intracellular proteins has recently been suggested in asthma, lung cancer and chronic bronchitis-COPD. In this mini-review, an overview of the biological roles of C/EBPs in lung is provided, together with a discussion of the recent studies suggesting a role for these transcription factors in the pathogenesis of some of our most common and severe lung diseases.
Export Options
About this article
Cite this article as:
Nord Magnus, C/EBP Transcription Factors in Lung Disease, Current Respiratory Medicine Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157339805774597956
DOI https://dx.doi.org/10.2174/157339805774597956 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms
Current Cancer Drug Targets INNO-206 (DOXO-EMCH), an Albumin-Binding Prodrug of Doxorubicin Under Development for Phase II Studies
Current Bioactive Compounds Hypocholesterolemia
Current Vascular Pharmacology Histone Deacetylase Inhibitors: Potent Anti-Leukemic Agents
Current Medicinal Chemistry Nucleoside Transporter Proteins
Current Vascular Pharmacology Research Advances on Anticancer Effect of Licorice
Current Bioactive Compounds The Molecular Bases of the Self-Renewal and Differentiation of Leukemic Stem Cells
Current Cancer Therapy Reviews Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Current Pharmaceutical Design New Therapeutic Strategies for Castration-Resistant Prostate Cancer
Recent Patents on Anti-Cancer Drug Discovery Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry From Bortezomib to other Inhibitors of the Proteasome and Beyond
Current Pharmaceutical Design Ginkgolic Acids Confer Potential Anticancer Effects by Targeting Pro- Inflammatory and Oncogenic Signaling Molecules
Current Molecular Pharmacology Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment
Current Cancer Drug Targets Using Naïve Bayes Algorithm to Estimate the Response to Drug in Lung Cancer Patients
Combinatorial Chemistry & High Throughput Screening Antiproliferative and Antifungal Activities of 1,3-diarylpropane-1,3-diones Commonly used as Sunscreen Agents
Letters in Drug Design & Discovery Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease?
Current Neurovascular Research Emerging Role of Stromal Fibroblasts in Epithelial Cancer
Current Signal Transduction Therapy Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly
Anti-Cancer Agents in Medicinal Chemistry Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology